Diabetes

Approximately 24 to 25% of patients with type 2 diabetes and heart failure died within 18 months.

New data from the EMPA-REG OUTCOME trial showed the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance) significantly reduced the incidence of worsening kidney disease in type 2 diabetes patients.

Merck and Pfizer teamed up to create a new type 2 diabetes drug.

Anti-fetal brain autoantibodies shown to be specific to some mothers of children with autism.

Metformin has been found to reduce the need for insulin in diabetics.

Diabetic macular oedema could be reduced by the cardiovascular drug darapladib.

Follow-on biologic drug MK-1293 deemed non-inferior to insulin glargine (Lantus).

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, outlines how pharmacists can optimize their role in creating hospital discharge plans for diabetes patients.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists out factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, discusses the types of goals pharmacists should discuss with patients with diabetes in order to avoid readmissions.

Treating type 2 diabetes with drugs and biologics that are most likely to be effective should be a health care priority.

Drug labels for canagliflozin and dapagliflozin revised to include acute injury warning.

Drug labels for canagliflozin and dapagliflozin revised to include acute injury warning.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists some factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, outlines how pharmacists can optimize their role in creating hospital discharge plans for diabetes patients.

A natural compound could increase the overall health of patients with diabetes, heart disease, and obesity.

Health-system pharmacists should fill their patients with diabetes in on the benefits of shared medical appointments after hospital discharge.

Katie Traylor, a PGY2 pharmacy resident in ambulatory care and family medicine, outlines the major glucose monitoring counseling points pharmacists can offer to patients prior to discharge.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes the major glucose monitoring counseling points pharmacists should offer to patients prior to discharge.

Pharmacists are the crux of successful care transitions between hospitals and post-acute care facilities.

Stopping hyperglycemia-induced beta cell death could prevent diabetes.

Patients with rheumatoid arthritis taking glucocorticoids in certain doses may have an increased risk of developing diabetes.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes how certain blood glucose monitors are designed to cater to certain health populations.

Treatment nearly doubled the risk of severe hypoglycemia that required medical attention in patients with type 2 diabetes.

This month, able-bodied Muslims around the world are fasting from dawn until dusk in observance of the holy month of Ramadan.